Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
Study NCT ID:
NCT04636333
Status:
UNKNOWN
Last Update Posted:
2022-03-31
First Post:
2020-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-07
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-17
First Submit QC Date:
None
Study First Post Date:
2020-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-28
Last Update Post Date:
2022-03-31
Last Update Post Date Type:
ACTUAL